Biomarkers in bronchiectasisEmma Johnson, James D. Chalmers, Merete Long|European Respiratory Review|2024Cited by 31
Proteinase 3 as a marker of clinical severity in bronchiectasis: Data from the EMBARC-BRIDGE studyEmma Johnson, James D. Chalmers, Arietta Spinou et al.|Unknown|2023Cited by 2
Sputum proteomics uncovers the heterogeneity of Pseudomonas aeruginosa infections in bronchiectasisRebecca C Hull, James D. Chalmers, Jamie Stobo et al.|Unknown|2024Cited by 1
Evaluation of rapid multiplex PCR for investigation of lung microbiology in bronchiectasis – preliminary data from the BRILLIANT studyLucy Bidgood, James D. Chalmers, Hollian Richardson et al.|Unknown|2024Cited by 0
Airway CD10/neprilysin is related to lung function and disease severity in patients with bronchiectasis: Preliminary data from the EMBARC BRIDGE studyHannah Dickson, James D. Chalmers, Rebecca C Hull et al.|Unknown|2025Cited by 0